Informa Markets will once again bring together the pharmaceutical industry at CPHI Americas 2026 (June 2-4), uniting senior leaders from across the pharmaceutical supply chain for a revamped conference focused event on contract manufacturing, regulatory change, artificial intelligence, and innovation in biologics and advanced therapies.

Part of the global CPHI portfolio, the annual event serves as a platform for pharmaceutical manufacturers, biotech companies, suppliers, and service providers to connect, share insights, and explore strategies to address industry-wide challenges.

The 2026 conference agenda is structured around key themes shaping the sector, including evolving regulatory frameworks, advances in artificial intelligence, supply chain resilience, and market positioning. Regulatory unpredictability remains a hot industry topic, and sessions will explore changes in US policy and approaches to risk-based decision-making. These include:

• FDA in Flux: Navigating the New Regulatory Landscape, featuring former US Department of Health and Human Services official Molly Klote and Highlander Health co-founder Amy Abernethy
• Global Risk Management and Risk-to-Value Transformation, led by Patrick Day, Principal Consultant at Lachman Consultants.

As investment in biologics accelerates, speakers will also examine the future of biotech innovation and funding strategies. Sessions include:

• The Evolving Biotech Innovation Ecosystem: What’s Ahead? with Murray Aitken, Executive Director at the IQVIA Institute
• Fueling Biotech Breakthroughs, featuring leaders from Likarda, BioLabs, Epivax and Morgan Stanley
• Revolutionizing Medicine: The Evolving Landscape of Cell & Gene Therapy in the U.S.

With continued pressure on global supply chains, sessions will focus on procurement strategies and external manufacturing models. These include:

• Building Resilient Supply Chains: Bayer’s Best Practices in Procurement and External Manufacturing, presented by Luiz Barberini
• The Future of Strategic Alliances in Pharma,” led by Mayank Nagar of Dr. Reddy’s.

Digitalization and cybersecurity remain critical priorities. Sessions will address supply chain threats, digital infrastructure and the application of artificial intelligence in drug discovery, including:

• Protecting Pharma: Ransomware, Social Engineering & Supply-Chain Threats, featuring the U.S. Secret Service
• Embedding AI Across Drug Discovery,” led by Emily Lewis of UCB.

As competition intensifies, the conference will also examine strategies for differentiation and communication.

• Future Market Strategy – Winning the Narrative as a Manufacturing Partner, featuring speakers from Bandwidth Solutions, LGM Pharma and Veranova.

Sarah Griffin, Event Manager at CPHI Americas, said: “CPHI Americas brings together leaders throughout the pharmaceutical supply chain to address the challenges shaping drug development and manufacturing.

She added: “This year’s agenda focuses on the areas having the greatest impact on the sector, including regulatory shifts, AI and biologics, providing attendees with practical insight they can apply within their organizations.”

Registration for CPHI Americas 2026 is now open. For more information and to view the full conference agenda, click here.

About Informa Markets

The CPHI portfolio includes 11 international events spanning Europe, the Americas, the Middle East, and Asia.

Informa Markets creates platforms for industries and specialist markets to trade, innovate, and grow. As part of Informa PLC, it delivers more than 450 B2B events annually across key sectors including healthcare, life sciences, construction, and fashion. The company’s mission is to foster global communities, enabling meaningful connections and commercial success.